.svg)
Pharma compliance software helps pharmaceutical organizations meet the regulatory requirements governing their operations and documents — GxP disciplines, 21 CFR Part 11 for electronic records and signatures, and health-authority submission standards — through validated systems, immutable audit trails, controlled document workflows, and defensible retention across research, manufacturing, quality, and commercial functions.
Research and clinical documentation with GCP-grade control; manufacturing and quality records under GMP (batch records, SOPs, deviations, CAPAs); regulatory submissions in prescribed structures; and promotional content through MLR review. The common thread is provable integrity: every document's status, version, and approval history is itself regulated data, and the system must enforce validated processes rather than rely on staff diligence — while producing audit trails that withstand inspection.
Pharma data — research, patient, and proprietary formulation information — carries strict handling and residency requirements, so where systems and any AI run matters. Cloud is viable for many document workflows, but sensitive and sovereign-bound data often requires private-cloud, on-premises, or air-gapped deployment. AI applied to pharma content (classification, extraction, search) must run inside the compliant boundary, via bring-your-own-model where public APIs are not permissible.
ioMoVo provides audit-trailed content and document management for pharma — immutable logging, electronic signatures, controlled workflows, and AI that runs inside your boundary — deployable on-premises or air-gapped. See the ioMoVo life sciences page.
Primarily GxP (GCP, GMP, GLP), 21 CFR Part 11 for electronic records and signatures, and regional health-authority submission and pharmacovigilance requirements.
Yes, with the right controls — but sensitive and sovereign-bound data often mandates private, on-premises, or air-gapped deployment, with AI running inside that boundary.